Recursion Prices $200 Million Stock Offering at $3.25 a Share

Recursion Pharmaceuticals priced an underwritten offering of 61,540,000 shares of Class A common stock at $3.25 per share. Expected gross proceeds total approximately $200 million before underwriting discounts, commissions and offering expenses; all shares will be sold by Recursion. The offering is expected to close on or about October 16, 2026, subject to customary closing conditions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via (Ref. ID: 202610150830PRIMZONEFULLFEED9846516) on October 15, 2026, and is solely responsible for the information contained therein. (C)